| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Outline of Final Research Achievements |
We conducted multicenter retrospective study evaluating the background and diagnostic opportunity for 651 primary hepatocellular carcinoma (HCC). The etiologies were 20.0% of hepatitis B virus (HBV), 36.3% of hepatitis C virus (HCV), and 43.4% of non-B non-C (NBNC). The characteristics of non-alcoholic NBNC HCC patients included high frequency of life-related diseases. 18.6% of cases were diagnosed by plain and conventional contrast enhanced CT. Compliance with the surveillance program for the diagnosis of HCC was 35.4% for HBV and 49.2% for HCV. The main causes of deviating the surveillance included unrecognized cases of HBV and HCV carrier, non-compliance with the surveillance program by physicians, and no medical care of HBV and HCV cases.
|
